Detalhe da pesquisa
1.
Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma.
Ann Hematol
; 103(1): 199-209, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792064
2.
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.
Hematol Oncol
; 41(4): 644-654, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254453
3.
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.
Haematologica
; 107(3): 690-701, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792219
4.
Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.
Blood
; 129(19): 2645-2656, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28288979
5.
FAM171B is a novel polyglutamine protein widely expressed in the mammalian brain.
Brain Res
; 1766: 147540, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052262
6.
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL.
Leukemia
; 35(2): 522-533, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32139889
7.
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
Blood Cancer J
; 10(11): 117, 2020 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168821
8.
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
Blood Cancer J
; 9(9): 73, 2019 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471540
9.
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma.
Sci Transl Med
; 11(497)2019 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31217338
10.
Enrichment of TP53 alterations within GCB-like DNA subclassifications of diffuse large B-cell lymphoma after transition from de-novo to relapsed or refractory disease.
Blood Res
; 57(2): 164-169, 2022 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551110